Merck and Moderna plot cancer vaccine expansion, China’s boom reshapes global venture investing, and more biotech news
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
We’re leaving room for popcorn and intrigue tonight: The new A24 documentary, “You Can See Everything,” hits theaters today.
I remember back at the American Chemical Society meeting in 2016, a skeptical pathologist told me in advance of a purported Theranos data unveil:
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Meghana Keshavan covers biotech and contributes to The Readout newsletter.
